My best ASX 200 shares to buy in January

There is a lot to like about these ASX 200 shares. Here's why they could be best buys.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • CSL remains a dominant force in the global blood plasma market despite disappointing in 2025, with short-term headwinds like margin pressures and weak flu vaccine sales creating a potential buying opportunity for patient investors willing to look past temporary setbacks.
  • Macquarie's diversified earnings across asset management, infrastructure, and capital markets help smooth returns through economic cycles, with its global expertise positioning it well for long-term investment trends despite some recent underperformance.
  • Woolworths' shares have fallen meaningfully from their highs, but the supermarket giant's ongoing investments in automation and digital capability could pay off as margin pressures ease and the competitive environment stabilises.

A new year often brings fresh optimism for investors, and January can be a great time to revisit an investment portfolio.

But which ASX 200 shares could be great picks for investors right now?

Let's take a look at three that I think are among the best to buy this month and for 2026:

A man holding a cup of coffee puts his thumb up and smiles while at laptop.

Image source: Getty Images

CSL Ltd (ASX: CSL)

It may have disappointed in 2025, but CSL remains one of the highest-quality companies on the Australian share market. The global biotech leader dominates the blood plasma market and has a deep pipeline of therapies that should be supportive of long-term earnings growth.

Short-term issues, including margin pressures, albumin demand, and weak influenza vaccine sales, have weighed on sentiment. But these factors don't change the core investment case. Demand for plasma therapies continues to grow globally, barriers to entry are extremely high, and CSL's scale gives it a significant competitive advantage.

For patient investors, January could be an attractive time to accumulate shares while the market remains cautious, rather than chasing the stock once momentum returns.

Macquarie Group Ltd (ASX: MQG)

Macquarie is Australia's leading global investment bank. Its earnings are diversified across asset management, infrastructure, commodities, and capital markets. This helps smooth returns across economic cycles.

While there has been underperformance in parts of its business in FY 2026, I don't expect this to be for long. Macquarie has a long history of adapting to changing conditions. Its asset management division continues to grow funds under management, while its infrastructure expertise positions it well for long-term global investment trends.

For investors looking for an ASX 200 share with exposure well beyond the domestic economy, Macquarie remains a high-quality option to consider early in the year.

Woolworths Group Ltd (ASX: WOW)

Woolworths may not be the most exciting stock on the market, but its reliability is exactly what makes it appealing. As one of Australia's dominant supermarket operators, it generates steady cash flow regardless of economic conditions.

Margin pressure and increased competition have been weighing on its performance over the past 12 months, but there are signs that the worst is now behind it. In addition, during this time Woolworths has continued to invest heavily in automation, supply chain efficiency, and digital capability. Over time, I believe these investments will bear fruit and position it for the future.

For investors building a balanced ASX 200 portfolio, Woolworths offers defensive characteristics that can complement higher-growth holdings. And with its shares down meaningfully from their highs, now could be an opportune time to load up on them.

Motley Fool contributor James Mickleboro has positions in CSL and Woolworths Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group and Woolworths Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

asx share price fall represented by investor with head in hands
Blue Chip Shares

Where to invest $20,000 in ASX shares after the market selloff

Market selloffs are hard in the moment but can be incredible buying opportunities.

Read more »

many investing in stocks online
Blue Chip Shares

Down 40%: 2 ASX 200 blue-chip shares to buy

Analysts at Morgans think these shares are dirt cheap at current levels.

Read more »

Woman with headphones on relaxing and looking at her phone happily.
Dividend Investing

2 ASX blue-chip shares offering big dividend yields

These large businesses have big dividend yields to match.

Read more »

Cheerful boyfriend showing mobile phone to girlfriend with a coffee mug in dining room.
Blue Chip Shares

3 excellent ASX shares I'd happily hold through the next market cycle

Instead of trying to predict market swings, I prefer focusing on businesses I would be comfortable holding through an entire…

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

3 blue chip ASX 200 shares I'd happily buy and hold through the next decade

Looking for blue-chip buys? Here are three that could be destined for big things.

Read more »

A young man wearing glasses and a denim shirt sits at his desk and raises his fists and screams with delight.
Blue Chip Shares

2 ASX 200 blue chip shares that could rise 50%

Analysts believe these shares could be undervalued.

Read more »

A person holds strong behind their umbrella as they weather the oncoming storm.
Blue Chip Shares

Experts rate these 2 ASX blue-chip shares as strong buys this month

These ASX blue-chip shares could be compelling picks amid the volatility.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Opinions

2 great ASX 200 blue-chip shares I'd buy right now

I think these stocks are undervalued after the results.

Read more »